• A global pharmaceutical group in a case before the French Competition Authority and the Paris court of appeal relating to an alleged abuse of collective dominance concerning the “off label use” of its drug in the ophthalmic field.
    • A global animal health company in a complaint before the European Commission leading to the investigation of a potentia “killer acquisition”.
    • Airbus in several critical acquisitions, including the acquisition of Bombardier’s CSeries aircraft, the creation of its joint venture with Safran in the defense and space sector, and the subsequent acquisition of Arianespace, the European space launch service provider.
    • Google in several abuse of dominance cases before the French Competition Authority and related private enforcement cases before French courts, including the largest private enforcement claim ever filed against Google in Europe.
    • A major automotive supplier in cartel proceedings before the European Commission, the U.S. DoJ and the Japanese Fair Trade Commission.
    • IBM in a number of cases before the French Competition Authority.
    • Amundi in its €3 billion acquisition of Pioneer Investment.
    • UTC in a number of cases before the French Competition Authority.
    • Lagardère in connection with the appeals brought before the General Court and the European Court of Justice by Odile Jacob against the European Commission decision approving Lagardère/Hachette’s €1.25 billion acquisition of Vivendi Universal Publishing (now called Editis) and related subsequent decisions of the European Commission.
    • Hachette in connection with distribution arrangements, as well as the design and implementation of a comprehensive antitrust compliance program.

    Includes matters handled at Dechert or prior to joining the firm.

    • Ecole Normale Supérieure, -, 2006
    • Institut d'Études Politiques de Paris, -, 2006
    • Université de Paris XI - Paris-Sud, M.A. in EU Business Law, 2007
    • Paris
    • Registered Foreign Lawyer, England and Wales
    • Antitrust Team Shortlisted for Four Writing Awards - (May 06, 2021)
    • DAMITT Q1 2021: Vertical Merger Challenges and New EU Referral Process Signal Transitions in U.S. and EU Investigations - (April 26, 2021)
    • European Commission repurposes powers to capture deals not meeting filing thresholds in the EU - (March 31, 2021)
    • DAMITT 2020 Report: Merger control in Germany and France - (February 04, 2021)
    • EU Court of Justice: Financial Investors Liable for Anticompetitive Conduct of Portfolio Companies - (January 29, 2021)
    • DAMITT 2020 Report: Antitrust merger enforcement trends amid the pandemic, U.S. elections and Brexit - (January 27, 2021) 
    • Antitrust Merger Reviews in the Time of COVID-19: How the Pandemic Is (and Is Not) Affecting Process and Timing - (March 31, 2020)
    • Impact of COVID-19 Coronavirus Pandemic on European Antitrust Enforcement - (March 26, 2020)
    • 2019 Annual Antitrust Spring Seminar - (March 26, 2019)
    • Private Equity Newsletter - (September 20, 2018)
    • Generali to Enter Strategic Partnership with Sycomore Asset Management - (September 07, 2018)
    • France: Merger Control - Global Competition Review - (June 01, 2018)
    • French
    • English
    • Paris Court of Appeal, Antitrust Section – Référendaire, Commissioner Maureen K. Ohlhausen
    • Roundtable Lettre des Juristes d’Affaires, Merger control : European Commission Guidelines on the article 22 – (July 2021)
    • Concurrences 12th New Frontiers of Antitrust Conference, Regulation of platforms: One size fits all? EU, UK, US, Germany – Webinar (June 11, 2021)
    • 8th Global Merger Control Conference — Webinars (December 2-4, 2020)
    • Advanced EU Competition Law Conference — Webinar (November 23-25, 2020)
    • GCR's Women in Antitrust conference — Webinar (November 17-18, 2020)
    • 7th Global Merger Control Conference — Paris, France (December 6, 2019)
    • First edition of the mentoring program W@CompetitionFR — Paris, France (July 4, 2019)